 | Up a level |
Litovkin, Kirill; Van Eynde, Aleyde; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Thomas; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Gramme, Pierre; Helleputte, Thibault; Isebaert, Sofie; Haustermans, Karin; Bollen, Mathieu (2015). DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS ONE, 10(6), e0130651. Public Library of Science 10.1371/journal.pone.0130651
Litovkin, Kirill; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Isebaert, Sofie; Haustermans, Karin; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu (2014). Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. Journal of cancer research and clinical oncology, 140(11), pp. 1849-1861. Springer 10.1007/s00432-014-1738-8
Kneitz, Burkhard; Krebs, Markus; Kalogirou, Charis; Schubert, Maria; Joniau, Steven; van Poppel, Hein; Lerut, Evelyne; Kneitz, Susanne; Scholz, Claus Jürgen; Ströbel, Philipp; Gessler, Manfred; Riedmiller, Hubertus; Spahn, Martin (2014). Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. Cancer research, 74(9), pp. 2591-2603. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-13-1606
Kalogirou, Charis; Spahn, Martin; Krebs, Markus; Joniau, Steven; Lerut, Evelyne; Burger, Maximilian; Scholz, Claus-Jürgen; Kneitz, Susanne; Riedmiller, Hubertus; Kneitz, Burkhard (2013). MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. International journal of molecular sciences, 14(11), pp. 21414-21434. MDPI 10.3390/ijms141121414
